Available at: Last accessed: April 2026 Rybelsus (oral semaglutide): US Prescribing Information
Foundayo (orforglipron) HCP was approved in the U.S
For both men and women, hormone changes may contribute to stubborn weight gain, difficulty losing weight, fatigue, and changes in overall wellness
Novo Nordisk, the manufacturer of Ozempic and Wegovy, provided the following statement to the BBC
It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists , which work by mimicking the action of a naturally occurring hormone in the body that regulates blood sugar levels
Safety Considerations and Cardiovascular Risk Tesofensine's sympathomimetic propertiesincreasing norepinephrine and dopamine activitycan raise blood pressure and heart rate